Literature DB >> 19095569

Evaluation of enzyme immunoassays to detect Clostridium difficile toxin from anaerobic stool culture.

Rosemary C She1, Robert J Durrant, Cathy A Petti.   

Abstract

Stool culture for Clostridium difficile, while necessary for strain typing and antimicrobial surveillance, cannot determine toxin production. We prospectively tested in triplicate 91 C difficile cultured isolates for toxin production by 2 enzyme immunoassays (EIAs) (Meridian Premier Toxins A&B, Meridian Bioscience, Cincinnati, OH; and TechLab Tox A/B II, TechLab, Blacksburg, VA) and cytotoxin neutralization bioassay (CTN). By CTN, 88% (80/91) were toxigenic. Reproducibility was 93% (85/91) for CTN, 80% (73/91) for Meridian EIA, and 79% (72/91) for TechLab EIA. Compared with CTN, sensitivities were 87.1% and 89.2% for the Meridian and TechLab EIAs, respectively. In an additional 115 stool specimens, CTN detected toxin more frequently from cultured isolates (96/115) than stool (84/115). For C difficile toxin detection from isolates, EIA was less reproducible than CTN. EIA methods can be falsely negative in 10% to 12% of isolates, and these should be tested by CTN or polymerase chain reaction. When positive, EIA is fast and reliable for detecting C difficile toxin from culture.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19095569     DOI: 10.1309/AJCPMM2E7VSPHNPG

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.

Authors:  Rémi Le Guern; Stéphanie Herwegh; Bruno Grandbastien; René Courcol; Frédéric Wallet
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

Review 2.  Virus-based chemical and biological sensing.

Authors:  Chuanbin Mao; Aihua Liu; Binrui Cao
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 3.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.

Authors:  Erik R Dubberke; Zhuolin Han; Linda Bobo; Tiffany Hink; Brenda Lawrence; Susan Copper; Joan Hoppe-Bauer; Carey-Ann D Burnham; William Michael Dunne
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

Review 5.  Current knowledge on the laboratory diagnosis of Clostridium difficile infection.

Authors:  Adrián Martínez-Meléndez; Adrián Camacho-Ortiz; Rayo Morfin-Otero; Héctor Jesús Maldonado-Garza; Licet Villarreal-Treviño; Elvira Garza-González
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

6.  Retrospective Definition of Clostridioides difficile PCR Ribotypes on the Basis of Whole Genome Polymorphisms: A Proof of Principle Study.

Authors:  Manisha Goyal; Lysiane Hauben; Hannes Pouseele; Magali Jaillard; Katrien De Bruyne; Alex van Belkum; Richard Goering
Journal:  Diagnostics (Basel)       Date:  2020-12-12

7.  Comparison of a frozen human foreskin fibroblast cell assay to an enzyme immunoassay and toxigenic culture for the detection of toxigenic Clostridium difficile.

Authors:  Alastair J Strachan; Natalie E Evans; O Martin Williams; Robert C Spencer; Rosemary Greenwood; Chris J Probert
Journal:  Diagn Microbiol Infect Dis       Date:  2012-10-26       Impact factor: 2.803

8.  Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).

Authors:  E Bouza; J M Aguado; L Alcalá; B Almirante; P Alonso-Fernández; M Borges; J Cobo; J Guardiola; J P Horcajada; E Maseda; J Mensa; N Merchante; P Muñoz; J L Pérez Sáenz; M Pujol; E Reigadas; M Salavert; J Barberán
Journal:  Rev Esp Quimioter       Date:  2020-02-20       Impact factor: 1.553

9.  Performance of commercial PCR assays to detect toxigenic Clostridioides difficile in the feces of puppies.

Authors:  Eman Anis; Denise Barnart; Amanda Barnard; Donna J Kelly; Laurel E Redding
Journal:  Vet Med Sci       Date:  2021-07-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.